Form 4 for BBIO BridgeBio Pharma, Inc.
Accepted 2021-08-06 00:00:00 ET · period of report 2021-08-04 · accession 0000899243-21-031954 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-08-06 | 2021-08-04 | BBIO | SCHELLER RICHARD H | See Remarks, Dir | S - Sale+OE | $53.23 | -13.8K | 45.9K | -23% | -$733.3K |
| D | 2021-08-06 | 2021-08-04 | BBIO | SCHELLER RICHARD H | See Remarks, Dir | M - OptEx | $17.00 | +13.8K | 59.6K | +30% | +$234.2K |
| D | 2021-08-06 | 2021-08-04 | BBIO | SCHELLER RICHARD H | See Remarks, Dir | M - OptEx | $0.00 | -13.8K | 39.6K | -26% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-04 | S | D | 13,777 | $53.23 | 45,860 | D | — | — | (F1) Represents the weighted average sale price of the shares sold from $52.839 to $53.68 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions as reported in this footnote. |
| 2 | Common | Common Stock | 2021-08-04 | M | A | 13,777 | $17.00 | 59,637 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2021-08-04 | M | D | 13,777 | $0.00 | 39,611 | D | $17.00 · — to 2029-06-26 | 13,777 Common Stock | (F2) The shares subject to this option vest and become exercisable in 48 equal monthly installments after June 26, 2019, subject to the Reporting Person's continued service to the Issuer through each such date. |